ADVERTISEMENT

New Products/Product News

The American Journal of Orthopedics. 2010 August;39(8):403-404
Author and Disclosure Information

Pedicle Screw System

Swede-O has introduced the Thermoskin OL Knee Brace, an offloading knee brace designed for patients who wish to continue

activities after injury, after surgery, or with arthritic conditions. Soft-molded condyle pads in this secure contact brace

provide joint line contact for exceptional medial and lateral stability. No tools are required to easily change flexion/extension

stop adjustments, which add extra protection in controlling range of motion as patients increase their range of activities.

Indications include instabilities of the anterior cruciate and/or posterior cruciate ligaments; instabilities of the medial collateral and/or lateral collateral ligaments; combined instabilities (with or without surgery); osteoarthritis; and degenerative joint disease.

The company notes that the brace features a rigid, durable, and lightweight aluminum frame construction and soft condyle pads to enhance stability and patient compliance. The hinge is easy to adjust without tools to save time, and holders on hinge pins minimize lost parts. Straps are numbered for ease of application, and the brace enables activity to promote muscle conditioning.

For more information, contact

Swede-O
6459 Ash Street
North Branch, MN 55056
phone (800) 525-9339
fax (651) 674-8425
www.swedeo.com

High-Speed Electric Drill

Medtronic, Inc., has announced availability of the company’s new Midas Rex® Legend® EHS Stylus Touch™ high-speed electric drill for spinal, cranial, and orthopedic surgical procedures. This is the first electric drill from Medtronic with integrated finger control and is based on the well-established Legend EHS Stylus® motor. With high torque and a compact size, the Legend EHS Stylus Touch drill offers excellent balance and maneuverability for procedures in tight anatomic spaces, according to Medtronic. Surgeons can operate the drill using finger control only, footpedal control, or both.

Medtronic notes that the Legend EHS Stylus Touch drill features ergonomic positioning and true variable-speed adjustment, easyto- use design and quick set-up, and adjustable speeds from 200 to 75,000 RPM. The Legend EHS Stylus Touch drill is powered by Medtronic’s Integrated Power Console (IPC®) system, a multispecialty surgical power console that offers improved intraoperative functionality. With the IPC system’s intuitive touchscreen interface, surgeons can use saved custom settings, quickly adjust irrigation via simple remote control, and run multiple Medtronic handpieces. As part of the standardized Legend platform, the Legend EHS Stylus Touch drill works with Medtronic’s interchangeable Legend tools and attachments for a broad range of surgical procedures.

To learn more, contact

Medtronic
710 Medtronic Parkway
Minneapolis, MN 55432
phone (800) 633- 8766
fax (763) 514-4879
www.medtronic.com

Bone Cement With Hydroxyapatite

Medtronic, Inc., announced the launch of KYPHON ActivOs 10 Bone Cement with Hydroxyapatite, a polymethylmethacrylate (PMMA) bone cement containing hydroxyapatite (HA) for use in the treatment of patients with vertebral compression fractures (VCFs) who are undergoing minimally invasive surgery with KYPHON® Balloon Kyphoplasty.

With this product, Medtronic now has a portfolio of cements offering surgeons a choice for treating VCF patients. Surgeons performing KYPHON Balloon Kyphoplasty can now use either KYPHON HV-R® Bone Cement, a PMMA bone cement, or KYPHON ActivOs 10 Bone Cement with Hydroxyapatite, a PMMA-HA composite bone cement.

HA is chemically and structurally similar to the mineral component of bone, has been widely studied,1 and has a long history of use in dental and orthopedic implants.

In a non-human trial* where KYPHON ActivOs 10 Bone Cement with Hydroxyapatite was implanted into 8 rabbit femurs, new bone was seen to form on the surface of the cement without an intervening fibrous tissue layer, and no inflammatory foreign body reaction was observed. This suggests that the surface of the cement is compatible with bone.

The complication rate with KYPHON Balloon Kyphoplasty has been demonstrated to be low.2 There are risks associated with the procedure (eg, cement leakage), including serious complications, and, though rare, some of these may be fatal. KYPHON® Balloon Kyphoplasty incorporates technology developed by Gary K. Michelson, MD.

For more information, contact

Medtronic
710 Medtronic Parkway
Minneapolis, MN 55432
phone (800) 633-8766
fax (763) 514- 4879
www.medtronic.com

Reference
1. LeGeros RZ. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop Relat Res. 2002;(395):81-98.
2. Based on analysis of 93 published studies with 5,690 KYPHON Balloon Kyphoplasty patients through April 4, 2010. The rate of cement-related symptomatic adverse events was 0.2%. Data on file as of June 21, 2010.

Telescoping Tissue Dissection Device

PEAK Surgical, Inc., announced the launch of the PEAK PlasmaBlade® 3.0S dissection device following 510(k) clearance from the US Food and Drug Administration (FDA). The company notes that this product features a 3.0-mm wide blade for greater cutting precision, integrated suction for enhanced visibility, and a telescoping shaft that extends from 5.5 cm to 15 cm for improved surgical access. The PlasmaBlade 3.0S is cleared for use in general; plastic and reconstructive; ear, nose, and throat (ENT); gynecologic; orthopedic; arthroscopic; spinal; and neurologic surgical procedures in the United States.
PEAK Surgical has initiated a series of clinical studies, called the PRECISE Studies ( Pulsed Plasma Radiofrequency Energy to ReduCe Thermal Injury and Improve Surgical HEaling), to examine the use of the Plasma- Blade in orthopedic, plastic and reconstructive, ENT, and oncologic surgery. Initial study results have been presented at various medical congresses, including American College of Surgeons and American Society of Breast Surgeons, and additional results are expected later this year. These study results have demonstrated that the PlasmaBlade was associated with significant improvements in the following endpoints as compared with the standard of care: 75% reduction in thermal injury depth (P=.001); 31% reduction in inflammation (P=.06); 49% reduction in postoperative narcotic consumption (P=.02); and 65% and 42% st rongerhealed incision strength at 3 and 6 weeks, respectively (P.001>

For more information, contact

PEAK Surgical
2464 Embarcadero Way
Palo Alto, CA, 94303
phone (650) 331-3020
www.peaksurgical.com